Physician profile
Vidya N Hate
NPI 1043312945
$998.84
in general payments reported to CMS, 2019-2025
19 companies · $83.25 in 2025
The $83.25 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $34.21 · 2021: $16.81 · 2022: $51.97 · 2023: $205 · 2024: $61.87 · 2025: $83.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.59 | 2019-2025 | |
| Therapeuticsmd, INC. | $153.84 | 2019 | |
| Hologic Sales and Service, LLC | $112.09 | 2019-2025 | Aptima, Coolseal Generator, Thinprep 2000 Processor |
| Astellas Pharma US INC | $91.49 | 2019-2020 | |
| Lilly USA, LLC | $88.45 | 2019-2024 | Mounjaro |
| Exact Sciences Corporation | $76.27 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $51.54 | 2019 | |
| Novo Nordisk INC | $50.87 | 2023-2025 | Ozempic, Rybelsus |
| Kowa Pharmaceuticals America, INC. | $23.86 | 2022 | |
| Applied Medical Resources Corporation | $19.07 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.48 | 2025 | Caplyta |
| Millicent US INC | $17.46 | 2019 | |
| Roche Diagnostics Corporation | $17.06 | 2019 | |
| Amgen INC. | $16.02 | 2019 | |
| Antares Pharma, INC. | $13.41 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $12.84 | 2020 | |
| Avion Pharmaceuticals | $12.05 | 2019 | |
| Merck Sharp & Dohme LLC | $11.88 | 2019 | |
| Daiichi Sankyo INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vidya Hate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.